0001231919-25-000181.txt : 20250903 0001231919-25-000181.hdr.sgml : 20250903 20250903114936 ACCESSION NUMBER: 0001231919-25-000181 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250903 DATE AS OF CHANGE: 20250903 EFFECTIVENESS DATE: 20250903 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHARM Therapeutics Inc. CENTRAL INDEX KEY: 0001889676 ORGANIZATION NAME: EIN: 872792129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-556495 FILM NUMBER: 251288185 BUSINESS ADDRESS: STREET 1: 33 FOLEY STREET CITY: LONDON STATE: X0 ZIP: W1W 7TL BUSINESS PHONE: 447582703655 MAIL ADDRESS: STREET 1: 33 FOLEY STREET CITY: LONDON STATE: X0 ZIP: W1W 7TL D 1 primary_doc.xml X0708 D LIVE 0001889676 CHARM Therapeutics Inc. 7 PANCRAS SQUARE LONDON X0 UNITED KINGDOM N1C 4AG 447582703655 DELAWARE None None Corporation true 2021 Gary Glick 7 PANCRAS SQUARE LONDON X0 UNITED KINGDOM N1C 4AG Executive Officer Director Promoter Rishi Gupta 7 PANCRAS SQUARE LONDON X0 UNITED KINGDOM N1C 4AG Director Nihal Sinha 7 PANCRAS SQUARE LONDON X0 UNITED KINGDOM N1C 4AG Director Matthew McAviney 7 PANCRAS SQUARE LONDON X0 UNITED KINGDOM N1C 4AG Director Mahesh Kudari 7 PANCRAS SQUARE LONDON X0 UNITED KINGDOM N1C 4AG Director Briggs Morrison 7 PANCRAS SQUARE LONDON X0 UNITED KINGDOM N1C 4AG Director Kim Blackwell 7 PANCRAS SQUARE LONDON X0 UNITED KINGDOM N1C 4AG Director Other Decline to Disclose 06b false 2025-08-19 false true true false 0 80095754 17290119 62805635 Total Offering Amount includes the conversion of $5,183,401.71 in Convertible Notes. false 20 0 0 0 false CHARM Therapeutics Inc. /s/ Gary Glick Gary D. Glick Chief Executive Officer 2025-09-03